Xencor (XNCR) Common Equity (2013 - 2026)

Xencor's (XNCR) quarterly Common Equity came in at $515.6 million in Q1 2026, down 19.42% year-on-year from $639.9 million in Q1 2025, and down 18.87% on a QoQ basis from $635.6 million in Q4 2025.

Xencor (XNCR) Common Equity (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Common Equity data on file, last reported at $515.6 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 19.42% year-over-year to $515.6 million in Q1 2026; TTM through Mar 2026 was $515.6 million, a 19.42% decrease from a year earlier, with the FY2025 full-year figure at $635.6 million, down 5.7% from the prior year.
  • Common Equity for Q1 2026 stood at $515.6 million, down from $635.6 million in the prior quarter.
  • Over the last five years, Common Equity for XNCR reached as high as $763.0 million in Q1 2022 and fell as low as $515.6 million in Q1 2026.
  • Historically, Common Equity has averaged $659.7 million across 5 years, with a median of $669.0 million in 2023.
  • Across the five-year window, Common Equity soared 30.74% in 2022 and fell 19.42% in 2026, its largest moves.
  • Year by year, Common Equity stood at $727.5 million in 2022, then slipped by 8.99% to $662.1 million in 2023, then advanced by 1.8% to $674.0 million in 2024, then decreased by 5.7% to $635.6 million in 2025, then declined by 18.87% to $515.6 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $515.6 million in Q1 2026, $635.6 million in Q4 2025, and $625.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Xencor 1.47 Bn 1.09 Bn - 515.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 515.63 Mn
Dec 31, 2025 635.59 Mn
Sep 30, 2025 625.32 Mn
Jun 30, 2025 620.35 Mn
Mar 31, 2025 639.87 Mn
Dec 31, 2024 674.03 Mn
Sep 30, 2024 705.93 Mn
Jun 30, 2024 548.71 Mn
Mar 31, 2024 599.73 Mn
Dec 31, 2023 662.09 Mn
Sep 30, 2023 669.01 Mn
Jun 30, 2023 678.88 Mn
Mar 31, 2023 683.58 Mn
Dec 31, 2022 727.50 Mn
Sep 30, 2022 722.70 Mn
Jun 30, 2022 742.34 Mn
Mar 31, 2022 763.02 Mn
Dec 31, 2021 733.50 Mn
Sep 30, 2021 618.86 Mn
Jun 30, 2021 646.94 Mn